$2.33
1.29%
Downside
Day's Volatility :8.73%
Upside
7.54%
34.33%
Downside
52 Weeks Volatility :68.78%
Upside
52.45%
Period | Monogram Technologies Inc | Index (Russel 2000) |
---|---|---|
3 Months | 11.11% | 0.0% |
6 Months | -7.34% | 0.0% |
1 Year | -2.83% | 0.0% |
3 Years | -79.57% | -22.2% |
Market Capitalization | 74.8M |
Book Value | $0.22 |
Earnings Per Share (EPS) | -0.2 |
Wall Street Target Price | 6.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -4076.01% |
Return On Assets TTM | -60.92% |
Return On Equity TTM | -121.56% |
Revenue TTM | 365.0K |
Revenue Per Share TTM | 0.01 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -14.5M |
Diluted Eps TTM | -0.2 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.45 |
EPS Estimate Next Year | -0.48 |
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Next Quarter | -0.1 |
What analysts predicted
Upside of 157.51%
Sell
Neutral
Buy
Monogram Technologies Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Monogram Technologies Inc | -26.61% | -7.34% | -2.83% | -79.57% | -79.57% |
Stryker Corporation | -4.4% | 4.86% | 34.65% | 34.77% | 67.22% |
Boston Scientific Corp. | 4.3% | 29.15% | 73.85% | 101.39% | 129.39% |
Edwards Lifesciences Corp. | -1.77% | -23.62% | -4.41% | -38.94% | -9.81% |
Abbott Laboratories | -1.28% | 6.64% | 25.97% | -1.23% | 45.48% |
Medtronic Plc | -0.83% | 11.38% | 24.54% | -28.4% | -16.93% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Monogram Technologies Inc | NA | NA | NA | -0.45 | -1.22 | -0.61 | NA | 0.22 |
Stryker Corporation | 39.69 | 39.69 | 2.6 | 12.01 | 0.19 | 0.07 | 0.01 | 51.86 |
Boston Scientific Corp. | 70.81 | 70.81 | 2.12 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
Edwards Lifesciences Corp. | 26.82 | 26.82 | 3.64 | 2.61 | 0.22 | 0.12 | NA | 12.35 |
Abbott Laboratories | 36.63 | 36.63 | 4.23 | 4.66 | 0.14 | 0.06 | 0.02 | 22.6 |
Medtronic Plc | 29.75 | 29.75 | 1.63 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Monogram Technologies Inc | NA | $74.8M | -79.57% | NA | 0.0% |
Stryker Corporation | Buy | $135.5B | 67.22% | 39.69 | 16.12% |
Boston Scientific Corp. | Buy | $128.3B | 129.39% | 70.81 | 12.0% |
Edwards Lifesciences Corp. | Buy | $41.0B | -9.81% | 26.82 | 23.74% |
Abbott Laboratories | Buy | $202.0B | 45.48% | 36.63 | 13.65% |
Medtronic Plc | Buy | $113.3B | -16.93% | 29.75 | 12.06% |
Insights on Monogram Technologies Inc
In the last 1 year, Boston Scientific Corp. has given 75.9% return, outperforming this stock by 82.9%
monogram is actively soliciting interest from independent distributors to represent our products. contact us to learn more about how you can get involved. "idiot proof joint replacements" high precision just-in-time patient matched implants that will be press-fit into high precision cavities prepared by our robotic system. by linking 3d printing and robotics via automated digital image analysis algorithms (machine learning) we are delivering a scalable solution for patient specific load bearing joint replacements.
Organization | Monogram Technologies Inc |
Employees | 28 |
CEO | Mr. Benjamin Sexson C.F.A. |
Industry | Miscellaneous |
Orion Energy Systems Inc
$2.33
-2.92%
Innovator Intl Developed Power Buffer Etf - June
$2.33
-2.92%
Bny Mellon Concentrated Intl
$2.33
-2.92%
Fidelity International Multifactor Etf
$2.33
-2.92%
Innovator Us Equity Accelerated Plus Etf - April
$2.33
-2.92%
Amplify Seymour Cannabis Etf
$2.33
-2.92%
Ebang International Holdings Inc
$2.33
-2.92%
Yieldmax Ai Option Income Strategy Etf
$2.33
-2.92%
First Trust Ultra Short Duration Municipal Etf
$2.33
-2.92%